Antiplasmodial Activity and Pharmacokinetic Profiling of Cryptolepine and 2,7-Dibromocryptolepine With a View to Informing the Design of Novel Antimalarial Cryptolepine Analogues.

Saved in:
Bibliographic Details
Title: Antiplasmodial Activity and Pharmacokinetic Profiling of Cryptolepine and 2,7-Dibromocryptolepine With a View to Informing the Design of Novel Antimalarial Cryptolepine Analogues.
Authors: Chenu E; MMV Medicines for Malaria Venture, Meyrin, Switzerland., Duffy J; MMV Medicines for Malaria Venture, Meyrin, Switzerland., Forkuo AD; Department of Pharmacology, Faculty of Pharmacy and Pharmaceutical Sciences, College of Health Sciences, Kwame Nkrumah University of Science and Technology (KNUST), Kumasi, Ghana., Gbedema SY; Department of Pharmaceutics, Faculty of Pharmacy and Pharmaceutical Sciences, College of Health Sciences, Kwame Nkrumah University of Science and Technology (KNUST), Kumasi, Ghana., Abdelall S; School of Pharmacy and Medical Sciences, University of Bradford, Bradford, UK., Wahajuddin M; Institute of Cancer Therapeutics, School of Pharmacy and Medical Sciences, University of Bradford, Bradford, UK., Jones HS; Institute of Cancer Therapeutics, School of Pharmacy and Medical Sciences, University of Bradford, Bradford, UK., Wright CW; School of Pharmacy and Medical Sciences, University of Bradford, Bradford, UK.
Source: Drug development research [Drug Dev Res] 2026 Apr; Vol. 87 (2), pp. e70245.
Publication Type: Journal Article
Journal Info: Publisher: Wiley-Liss Country of Publication: United States NLM ID: 8204468 Publication Model: Print Cited Medium: Internet ISSN: 1098-2299 (Electronic) Linking ISSN: 02724391 NLM ISO Abbreviation: Drug Dev Res Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1098-2299
DOI:10.1002/ddr.70245